Hyderabad: Bharat Biotech has actually chosen to increase its vaccine production capability for Covaxin by including yet another assembly line at its Ankleshwar-based subsidiary, Chiron Behring Vaccines.
The company has actually currently been producing its Covid-19 vaccine at its Hyderabad and Bengaluru facilities.The business said it plans to produce 20 crore doses of Covaxin per year in the GMP centers that are already operational for the production of vaccines.
The product availability at Ankleshwar, the company said, will commence from October 2021.
The additional manufacturing at Chiron Behring would efficiently take the volumes approximately 100 crore doses per annum, with its own established campuses.